These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33927197)

  • 1. Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases.
    van de Berg D; Kis Z; Behmer CF; Samnuan K; Blakney AK; Kontoravdi C; Shattock R; Shah N
    NPJ Vaccines; 2021 Apr; 6(1):65. PubMed ID: 33927197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality by Digital Design for Developing Platform RNA Vaccine and Therapeutic Manufacturing Processes.
    Nair A; Loveday KA; Kenyon C; Qu J; Kis Z
    Methods Mol Biol; 2024; 2786():339-364. PubMed ID: 38814403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by Design for enabling RNA platform production processes.
    Daniel S; Kis Z; Kontoravdi C; Shah N
    Trends Biotechnol; 2022 Oct; 40(10):1213-1228. PubMed ID: 35491266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilizing vaccines via drying: Quality by design considerations.
    Ghaemmaghamian Z; Zarghami R; Walker G; O'Reilly E; Ziaee A
    Adv Drug Deliv Rev; 2022 Aug; 187():114313. PubMed ID: 35597307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the potential of machine learning for advancing "Quality by Design" in biomanufacturing.
    Walsh I; Myint M; Nguyen-Khuong T; Ho YS; Ng SK; Lakshmanan M
    MAbs; 2022; 14(1):2013593. PubMed ID: 35000555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.
    Peltonen L
    Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30044395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid development and deployment of high-volume vaccines for pandemic response.
    Kis Z; Kontoravdi C; Dey AK; Shattock R; Shah N
    J Adv Manuf Process; 2020 Jul; 2(3):e10060. PubMed ID: 33977274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information Processing: Rate-Based Investigation of Cell Physiological Changes along Design Space Development.
    Sagmeister P; Wechselberger P; Herwig C
    PDA J Pharm Sci Technol; 2012; 66(6):526-41. PubMed ID: 23183649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality by Design Framework Applied to GMMA Purification.
    Giannelli C; Necchi F; Palmieri E; Oldrini D; Ricchetti B; Papathanasiou MM; Kis Z; Kontoravdi C; Campa C; Micoli F
    AAPS J; 2024 Mar; 26(2):32. PubMed ID: 38459151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach.
    Liu H; Rivnay B; Avery K; Myung JH; Kozak D; Landrau N; Nivorozhkin A; Ashraf M; Yoon S
    Int J Pharm; 2020 Jul; 585():119473. PubMed ID: 32473373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Study of Intermediate and Critical Quality Attributes for Process Control of High-Shear Wet Granulation Using Multivariate Analysis and The Quality by Design Approach.
    Han JK; Shin BS; Choi DH
    Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design-for-Six-Sigma for Development of a Bioprocess Quality-by-Design Framework.
    Junker B; Kosinski M; Geer D; Mahajan R; Chartrain M; Meyer B; Dephillips P; Wang Y; Henrickson R; Ezis K; Waskiewicz M
    PDA J Pharm Sci Technol; 2011; 65(3):254-86. PubMed ID: 22293236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding pharmaceutical quality by design.
    Yu LX; Amidon G; Khan MA; Hoag SW; Polli J; Raju GK; Woodcock J
    AAPS J; 2014 Jul; 16(4):771-83. PubMed ID: 24854893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Technologies for Low-Cost, Rapid Vaccine Manufacture.
    Kis Z; Shattock R; Shah N; Kontoravdi C
    Biotechnol J; 2019 Jan; 14(1):e1800376. PubMed ID: 30537361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Saccharomyces cerevisiae fermentation process for production of a therapeutic recombinant protein using a multivariate Bayesian approach.
    Fu Z; Baker D; Cheng A; Leighton J; Appelbaum E; Aon J
    Biotechnol Prog; 2016 May; 32(3):799-812. PubMed ID: 27095416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QbD-Guided Traditional Chinese Medicine Manufacturing Process: Development and Optimization of Fluid-Bed Granulation and Drying Processes for Xiaochaihu Capsules.
    Teng K; Fu H; Wu G; Gong P; Xie Y; Zhou P; Gong X; Qu H
    AAPS PharmSciTech; 2023 Oct; 24(7):210. PubMed ID: 37821749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QbD Approach towards Robust Design Space for Flutamide/PiperineSelf-Emulsifying Drug Delivery System with Reduced Liver Injury.
    Saha M; Sikder P; Saha A; Shah S; Sultana S; Emran T; Banik A; Islam Z; Islam MS; Sharker SM; Reza HM
    AAPS PharmSciTech; 2022 Jan; 23(1):62. PubMed ID: 35080685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of an herbal material quality control strategy considering the effects of manufacturing processes.
    Pan J; He S; Zheng J; Shao J; Li N; Gong Y; Gong X
    Chin Med; 2019; 14():38. PubMed ID: 31572490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
    Sandbrink JB; Shattock RJ
    Front Immunol; 2020; 11():608460. PubMed ID: 33414790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.